🌱 KidneyEnergy.com

← brief for 2026-11-12 · Slowing decline

Phenylbutyrate-Derived Nitric Oxide Donor Attenuates Renal Fibrosis through the Extracellular Matrix Degradation Pathway.

Article D Peer reviewed Preclinical

Key takeaways

A new drug called NPB was tested in mice with kidney disease. It helped lower waste levels and reduced scarring in the kidneys. This was done in animals, not people yet. It shows promise for slowing kidney decline, but human trials are needed.

Who did this work

Arimura Y · Beppu T · Imoto S · Tamori A · Hosokawa H · Hirahara E · Tsukigawa K · Tokuno M · Otagiri M · Yamasaki K · Ueno-Shuto K · Nishi K

Source

Article · PubMed, CKD progression · 2026 Oct 5
https://pubmed.ncbi.nlm.nih.gov/43020532/